Star Therapeutics

Star Therapeutics is owned by InvoX Pharma. InvoX Pharma has a direct presence in 2 countries.

They are in:

• Biotechnology67%
• Pharmaceuticals33%

View the org chart displaying its 13 main executives

Most searched biographies at Star Therapeutics

• Adam Rosenthal, Chief Executive Officer
• Carl Gordon, Director
• Amrit Nagpal, Director

Popular executive movements at Star Therapeutics

• Scott Robertson has joined the company as Chief Business Officer and Chief Financial Officer  (posted on January 3 2024).
• Matthew Fust has joined the company as Independent Director  (posted on December 6 2023).

Create your alert
to follow the executive moves at Star Therapeutics.

InvoX Pharma has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Star Therapeutics

• Backed by $100M, Star Therapeutics sets out to find constellations of rare disease - STAR Therapeutics
• News - STAR Therapeutics

Social media about Star Therapeutics

• Star Therapeutics on Wikipedia, Google News & Yahoo Finance
• Star Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Adam Rosenthal

Call Star Therapeutics at +1 888...

View the org chart

Register to receive your alert

Report an error